Thermo Fisher (TMO) announced that its board of directors has authorized the repurchase of $4B of shares of its common stock in the open market ...

Thermo Fisher Scientific Inc. (TMO) announced Friday that its Board of Directors has authorized the repurchase of $4 billion of ...

Thermo Fisher Scientific's board has approved a new $4 billion stock buyback program. The Waltham, Mass., Life-sciences giant on Friday said the new program has no expiration date and replaces its ...

Thermo Fisher Scientific Inc. is proposing to build a new “corporate hangar and office facility” at the Portsmouth ...

Thermo Fisher Scientific has signed an agreement with Mainz Biomed to develop and launch a next-generation colorectal cancer ...

Thermo Fisher Scientific has good revenue and margin growth prospects ahead and is trading at a discount. See why TMO stock ...

The medical device maker has completed more than 40 acquisitions in recent years, helping turn it into one of the state’s ...

Thermo Fisher Scientific has signed an agreement with German molecular genetics company Mainz Biomed, the developer of ...

Thermo Fisher Scientific (NYSE:TMO) is closing a facility as part of a shift in operations across Massachusetts.

at a negative CAGR of 42.8% from 2024 through 2029. European Life Science Tools and Reagents Market Scope Full List of Company Profiles Included in this Report: ...

the company highlighted applications of the technology in the context of neurodegenerative disease, cancer, and metabolic ...